Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight and diagnose cancer and other diseases. Our lead compound, GB-13, is currently advancing toward a Phase I clinical trial for several cancer targets. GB-13 is a genetically engineered recombinant protein that specifically binds and destroys cancer cells with minimal normal cell damage. We have also licensed related technology for a cancer immunotherapy that is in Phase III clinical trials.
Company Details
- Employees
- 4
- Address
- 475 West Govenor Rd., Hershey,pa 17033,united States
- Phone
- (717) 571-2402
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- targepeutics.com
- Keywords
- Cancer and Precision Medicine.
- HQ
- Hershey, PA
Targepeutics Questions
Targepeutics's helpline number is (717) 571-2402
Targepeutics's website is targepeutics.com
Targepeutics's LinkedIn profile is https://www.linkedin.com/company/targepeutics
Targepeutics has
4 employees.
View email and phone details for 4
employees at Targepeutics.
Targepeutics's industry is
Biotechnology Research
Targepeutics's top competitors are
Plexision,
Vention,
Tr Media World,
Otiniano Dynasty,
Innovate Gbm,
Smoke Cycle Llc,
Yuvaan Tiwari Foundation,
Aktis Oncology,
Troy Manufacturing, Inc.,
Vivopharm Llc - A Reaction Biology Company.
Targepeutics's categories are Biotechnology Research
